New immune cell therapy tested for tough leukemia cases
NCT ID NCT07361029
Summary
This is an early-stage safety study testing a new type of CAR-T cell therapy for adults with acute lymphoblastic leukemia (ALL) that has come back or hasn't responded to other treatments. The main goal is to find a safe dose and understand the side effects. Researchers will also check if the treatment shows any early signs of fighting the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
King Faisal Specialist Hospital and Research Center
RECRUITINGRiyadh, Riyadh Region, Saudi Arabia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.